Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


15.10.2018

1 Aliment Pharmacol Ther
2 Am J Gastroenterol
5 Dig Dis Sci
2 Gastroenterol Hepatol
1 Gut
10 Inflamm Bowel Dis
8 J Crohns Colitis
2 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. CHU TPC, Grainge MJ, Card TR
    The risk of venous thromboembolism during and after hospitalisation in patients with inflammatory bowel disease activity.
    Aliment Pharmacol Ther. 2018 Oct 8. doi: 10.1111/apt.15010.
    PubMed     Text format     Abstract available


    Am J Gastroenterol


  2. Clinical Vignettes/Case Reports - Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0342.
    PubMed     Text format    


  3. Inflammatory Bowel Disease.
    Am J Gastroenterol. 2018 Oct 8. pii: 10.1038/s41395-018-0327.
    PubMed     Text format    


    Dig Dis Sci

  4. MA C, Ascoytia C, McCarrier KP, Martin M, et al
    Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.
    Dig Dis Sci. 2018;63:2555-2563.
    PubMed     Text format     Abstract available

  5. NASSER Y, Labetoulle R, Harzallah I, Berger AE, et al
    Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Dig Dis Sci. 2018;63:2714-2721.
    PubMed     Text format     Abstract available

  6. KEDIA S, Jain S, Goyal S, Bopanna S, et al
    Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
    Dig Dis Sci. 2018;63:2747-2753.
    PubMed     Text format     Abstract available

  7. PATIL SA, Cross RK
    More Skin in the Game: Screening for Skin Cancer in IBD Patients.
    Dig Dis Sci. 2018;63:2497-2499.
    PubMed     Text format    

  8. LEE D, Swan CK, Suskind D, Wahbeh G, et al
    Children with Crohn's Disease Frequently Consume Select Food Additives.
    Dig Dis Sci. 2018;63:2722-2728.
    PubMed     Text format     Abstract available


    Gastroenterol Hepatol

  9. GUARDIOLA J, Lobaton T, Cerrillo E, Ferreiro-Iglesias R, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the utility of the determination of faecal calprotectin in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018;41:514-529.
    PubMed     Text format     Abstract available

  10. RODRIGUEZ-LAGO I, Ferreiro-Iglesias R, Nos P, Gisbert JP, et al
    Management of acute severe ulcerative colitis in Spain: A nationwide clinical practice survey.
    Gastroenterol Hepatol. 2018 Oct 4. pii: S0210-5705(18)30251.
    PubMed     Text format     Abstract available


    Gut

  11. HAMMOUDI N, Gardair C, Tran-Minh ML, Allez M, et al
    Rare cause of rectal stenosis in a patient with long-term use of Infliximab and Mercaptopurine for ulcerative colitis.
    Gut. 2018 Oct 9. pii: gutjnl-2018-317069. doi: 10.1136/gutjnl-2018-317069.
    PubMed     Text format     Abstract available


    Inflamm Bowel Dis

  12. GREENSTEIN R, Brown S
    A Data-Based Hypothesis That Inflammatory Bowel Disease Unclassified (IBD-U) May Indicate That IBD Is a Spectrum of a Single Infectious Intestinal Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5116939. doi: 10.1093.
    PubMed     Text format    

  13. BATTAT R, Dulai PS, Vande Casteele N, Evans E, et al
    Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117434. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. TRAN L, Mulligan K
    A Systematic Review of Self-Management Interventions for Children and Adolescents With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5117847. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. REINISCH W, Bressler B, Curtis R, Parikh A, et al
    Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5119830. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. COTE-DAIGNEAULT J, Bessissow T, Nicolae MV, Nie R, et al
    Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120076. doi: 10.1093.
    PubMed     Text format     Abstract available

  17. GRINDAL AW, Khan R, Scaffidi MA, Rumman A, et al
    Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines.
    Inflamm Bowel Dis. 2018 Oct 5. pii: 5120389. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. EGBERG MD, Galanko JA, Barnes EL, Kappelman MD, et al
    Thrombotic and Infectious Risks of Parenteral Nutrition in Hospitalized Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 10. pii: 5126394. doi: 10.1093.
    PubMed     Text format     Abstract available

  19. LUKIN DJ, Lawlor G, Hudesman DP, Durbin L, et al
    Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5124548. doi: 10.1093.
    PubMed     Text format     Abstract available

  20. TINSLEY A, Navabi S, Williams ED, Liu G, et al
    Erratum to Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018 Oct 12. pii: 5128779. doi: 10.1093.
    PubMed     Text format    

  21. KATSANOS KH, Saridi M, Albani E, Mantzouranis G, et al
    Sexual Dysfunction in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2018;24:2348-2349.
    PubMed     Text format    


    J Crohns Colitis

  22. SANDBORN WJ, Colombel JF, Panaccione R, Dulai PS, et al
    Deep remission with vedolizumab in patients with moderately to severely active ulcerative colitis: a GEMINI 1 post hoc analysis.
    J Crohns Colitis. 2018 Oct 4. pii: 5114646. doi: 10.1093.
    PubMed     Text format     Abstract available

  23. ARMUZZI A, Avedano L, Greveson K, Kang T, et al
    Nurses are critical in aiding patients transitioning to biosimilars in inflammatory bowel disease: education and communication strategies.
    J Crohns Colitis. 2018 Oct 4. pii: 5114647. doi: 10.1093.
    PubMed     Text format     Abstract available

  24. BURISCH J, Katsanos KH, Christodoulou DK, Barros L, et al
    Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study.
    J Crohns Colitis. 2018 Oct 5. pii: 5115808. doi: 10.1093.
    PubMed     Text format     Abstract available

  25. MACALUSO FS, Fries W, Privitera AC, Cappello M, et al
    A propensity score-matched comparison of infliximab and adalimumab in TNF-alpha inhibitors naive and non-naive patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD).
    J Crohns Colitis. 2018 Oct 6. pii: 5122861. doi: 10.1093.
    PubMed     Text format     Abstract available

  26. GISBERT JP, Chaparro M
    Clinical usefulness of proteomics in inflammatory bowel disease: A comprehensive review.
    J Crohns Colitis. 2018 Oct 10. pii: 5126442. doi: 10.1093.
    PubMed     Text format     Abstract available

  27. NGUYEN GC, Bouchard S, Diong C
    Access to Specialists and Emergency Department Visits in Inflammatory Bowel Disease: A Population-Based Study.
    J Crohns Colitis. 2018 Oct 12. pii: 5127082. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. MEGE D, Colombo F, Stellingwerf ME, Germain A, et al
    Risk factors for small bowel obstruction after laparoscopic ileal pouch-anal anastomosis for inflammatory bowel disease. A multivariate analysis in 4 expert centres in Europe.
    J Crohns Colitis. 2018 Oct 11. pii: 5127081. doi: 10.1093.
    PubMed     Text format     Abstract available

  29. SAHAMI S, Wildenberg ME, Koens L, Doherty G, et al
    Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation: Short-Term Results of the PASSION Study.
    J Crohns Colitis. 2018 Oct 3. pii: 5114636. doi: 10.1093.
    PubMed     Text format     Abstract available


    Scand J Gastroenterol

  30. KATARINA PL, Sussanne B, Gunilla HF, Henrik H, et al
    The quality of care questionnaire: development of a valid measure for persons with inflammatory bowel disease.
    Scand J Gastroenterol. 2018 Oct 9:1-8. doi: 10.1080/00365521.2018.1495759.
    PubMed     Text format     Abstract available

  31. O'MORAIN N, O'Gorman S, McNamara D, Ryan B, et al
    Patients' attitudes toward treatment withdrawal in inflammatory bowel disease.
    Scand J Gastroenterol. 2018 Oct 9:1. doi: 10.1080/00365521.2018.1511827.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: